A natriuretic peptides clearance receptor’s agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure
- 1 September 2017
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 93, 1144-1150
Abstract
No abstract availableKeywords
Funding Information
- Heart and Stroke Foundation of Canada
This publication has 34 references indexed in Scilit:
- Pulmonary Pressures and Death in Heart FailureJACC, 2012
- Prevalence and Risk Factors of Pulmonary Hypertension in Patients With Elevated Pulmonary Venous Pressure and Preserved Ejection FractionThe American Journal of Cardiology, 2010
- Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionJACC, 2009
- Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptorBiochemical and Biophysical Research Communications, 2007
- Left ventricular pressure-volume relationship in conscious miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Natriuretic Peptide Receptor-C Regulates Coronary Blood Flow and Prevents Myocardial Ischemia/Reperfusion InjuryCirculation, 2004
- Cytoplasmic Domain of Natriuretic Peptide Receptor C Constitutes Gi Activator Sequences That Inhibit Adenylyl Cyclase ActivityJournal of Biological Chemistry, 2001
- Cytoplasmic Domain of Natriuretic Peptide Receptor-C Inhibits Adenylyl CyclaseJournal of Biological Chemistry, 1996
- Physiological Role of Silent Receptors of Atrial Natriuretic FactorScience, 1987
- Atrial natriuretic factor receptors are negatively coupled to adenylate cyclase in cultured atrial and ventricular cardiocytesBiochemical and Biophysical Research Communications, 1986